ON-DEMAND WEBINAR
Reagents, Tools, and Custom Services For Characterizing Biologic Drug Potency
Evaluating the potential impact of immunogenicity on drug efficacy, safety, and overall patient well-being is critical when developing and characterizing biologic drugs to fulfill regulatory requirements and pave the way for safer and more personalized drug therapies. In this webinar, you will gain valuable insights into the various methods for characterizing and quantifying monoclonal antibody therapeutics. Together we'll also explore immunoassays and reagents for evaluating PD, PK, and immunogenic properties of the antibody drug substance or drug product and ways to identify and differentiate particular antibody drugs manufactured on similar antibody architecture.
Join the webinar to learn:
Monoclonal Antibody Therapeutics
Anti-idiotypic (anti-ID) antibodies and the types of anti-ID antibodies
The various roles of anti-ID antibodies in biologic drug development and characterization
Effector/target cell products that can be combined with antibody modalities for functional readouts
ADCP and ADCC products to measure antibody activation
Presenters:
Nicholas Hess, PhD
Product Manager - Promega
With degrees from University of Minnesota-Duluth and University of Illinois at Urbana-Champaign, Nicholas Hess has extensive experience in the immunology/cell therapy field as well as in product management.
Renee Salvo, PhD
Product Manager - Rockland
With degrees from King's College, The University of Scranton, and a PhD in Biochemistry from the University of the Sciences in Philadelphia, PA (USA), Renee is a seasoned global product manager focused in the Cell, Gene, and RNA Therapeutics space.
© 2023 Rockland Immunochemicals, Inc.